Catalent, Inc. 0C8.F Stock
Catalent, Inc. Price Chart
Catalent, Inc. 0C8.F Financial and Trading Overview
Catalent, Inc. stock price | 53.04 EUR |
Previous Close | 40.05 EUR |
Open | 39.45 EUR |
Bid | 39.75 EUR x 150000 |
Ask | 39.9 EUR x 150000 |
Day's Range | 39.45 - 39.45 EUR |
52 Week Range | 29.2 - 111.04 EUR |
Volume | 100 EUR |
Avg. Volume | 71 EUR |
Market Cap | 7.11B EUR |
Beta (5Y Monthly) | 1.180985 |
PE Ratio (TTM) | 164.375 |
EPS (TTM) | -6.69 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 150.92 EUR |
0C8.F Valuation Measures
Enterprise Value | 11.83B EUR |
Trailing P/E | 164.375 |
Forward P/E | 9.987342 |
PEG Ratio (5 yr expected) | 2.41 |
Price/Sales (ttm) | 1.5821425 |
Price/Book (mrq) | 1.5098745 |
Enterprise Value/Revenue | 2.631 |
Enterprise Value/EBITDA | 13.915 |
Trading Information
Catalent, Inc. Stock Price History
Beta (5Y Monthly) | 1.180985 |
52-Week Change | -57.88% |
S&P500 52-Week Change | 20.43% |
52 Week High | 111.04 EUR |
52 Week Low | 29.2 EUR |
50-Day Moving Average | 41.91 EUR |
200-Day Moving Average | 55.9 EUR |
0C8.F Share Statistics
Avg. Volume (3 month) | 71 EUR |
Avg. Daily Volume (10-Days) | 4 EUR |
Shares Outstanding | 180.27M |
Float | 179.51M |
Short Ratio | N/A |
% Held by Insiders | 0.36% |
% Held by Institutions | 105.82% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | June 30, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | June 30, 2023 |
Profitability
Profit Margin | 0.48% |
Operating Margin (ttm) | 9.83% |
Gross Margin | 28.63% |
EBITDA Margin | 18.91% |
Management Effectiveness
Return on Assets (ttm) | 2.61% |
Return on Equity (ttm) | 0.47% |
Income Statement
Revenue (ttm) | 4.5B EUR |
Revenue Per Share (ttm) | 25.11 EUR |
Quarterly Revenue Growth (yoy) | -18.50% |
Gross Profit (ttm) | 1.64B EUR |
EBITDA | 850M EUR |
Net Income Avi to Common (ttm) | 21M EUR |
Diluted EPS (ttm) | 0.24 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 252M EUR |
Total Cash Per Share (mrq) | 1.4 EUR |
Total Debt (mrq) | 4.86B EUR |
Total Debt/Equity (mrq) | 103.34 EUR |
Current Ratio (mrq) | 1.841 |
Book Value Per Share (mrq) | 26.128 |
Cash Flow Statement
Operating Cash Flow (ttm) | 127M EUR |
Levered Free Cash Flow (ttm) | -508000000 EUR |
Profile of Catalent, Inc.
Country | Germany |
State | NJ |
City | Somerset |
Address | 14 Schoolhouse Road |
ZIP | 08873 |
Phone | 732 537 6200 |
Website | https://www.catalent.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 19000 |
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. The Biologics segment provides biologic cell-line; develops and manufactures cell therapy and viral based gene therapy; formulation, development, and manufacturing for parenteral dose forms, including vials, prefilled syringes, vials, and cartridges; and analytical development and testing services. The Oral and Specialty Delivery segment offers formulation, development, and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. This segment also offers oral delivery solutions platform comprising pre-clinical screening, formulation, analytical development, and current good manufacturing practices services. The Clinical Supply Services segment offers manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics, and cell and gene therapies in clinical trials. The company also offers FlexDirect direct-to-patient and FastChain demand-led clinical supply services. It serves pharmaceutical, biotechnology, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. The company was incorporated in 2007 and is headquartered in Somerset, New Jersey.
Q&A For Catalent, Inc. Stock
What is a current 0C8.F stock price?
Catalent, Inc. 0C8.F stock price today per share is 53.04 EUR.
How to purchase Catalent, Inc. stock?
You can buy 0C8.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Catalent, Inc.?
The stock symbol or ticker of Catalent, Inc. is 0C8.F.
Which industry does the Catalent, Inc. company belong to?
The Catalent, Inc. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Catalent, Inc. have in circulation?
The max supply of Catalent, Inc. shares is 180.74M.
What is Catalent, Inc. Price to Earnings Ratio (PE Ratio)?
Catalent, Inc. PE Ratio is now.
What was Catalent, Inc. earnings per share over the trailing 12 months (TTM)?
Catalent, Inc. EPS is -6.69 EUR over the trailing 12 months.
Which sector does the Catalent, Inc. company belong to?
The Catalent, Inc. sector is Healthcare.